Lipodystrophy and metabolic complications of highly active antiretroviral therapy

Ankit Parakh1, Anand Prakash Dubey, Ajay Kumar

  • 1Department of Pediatrics, Maulana Azad Medical College and Associated Hospitals, New Delhi, India. ankitparakh102@rediffmail.com

Insights

Metabolic abnormalities and lipodystrophy are emerging complications in Indian children receiving first-line highly active antiretroviral therapy (HAART). Close follow-up is crucial for managing these potential side effects.

Area of Science:

  • Pediatric infectious diseases
  • Pharmacology and toxicology
  • Metabolic disorders

Background:

  • Highly active antiretroviral therapy (HAART) is the standard of care for HIV-infected children.
  • Understanding the metabolic toxicities of first-line HAART regimens is essential for long-term patient management.
  • Body fat redistribution (lipodystrophy) is a known concern with antiretroviral drugs.

Purpose of the Study:

  • To evaluate metabolic drug toxicities associated with WHO-recommended generic HAART in children.
  • To determine the prevalence of body fat redistribution (lipoatrophy and lipohypertrophy) in this population.
  • To identify risk factors contributing to these adverse effects.

Main Methods:

  • A cross-sectional observational study involving 52 HIV-infected children (25 on HAART, 27 controls).
  • Assessment included sociodemographic, clinical, and immunological data.
  • Physical examination for lipodystrophy, and laboratory tests for liver function, blood sugar, lipids, amylase, lactate, pH, and bicarbonate.

Main Results:

  • Children on HAART (stavudine/zidovudine-based) showed lower weight-for-age and BMI, but similar height-for-age compared to controls.
  • Two cases of peripheral lipoatrophy and four cases of hypercholesterolemia were observed in the HAART group.
  • Asymptomatic mild hyperlactatemia occurred in four children; no hyperglycemia or liver impairment was noted.

Conclusions:

  • Metabolic abnormalities and lipodystrophy are emerging complications of HAART in Indian children.
  • These findings highlight the need for vigilant monitoring and follow-up.
  • Larger, longitudinal studies are recommended to further elucidate these complications.
Abstract

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...